Community-onset healthcare-associated MRSA bacteraemia in a district general hospital

J A Karas1, D A Enoch, M M Emery

  • 1Department of Infection Control, Hinchingbrooke Hospital, Huntingdon, UK. andreas.karas@papworth.nhs.uk

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia leads to high mortality. Early empirical therapy and increased screening are crucial for managing MRSA infections in at-risk patients.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Epidemiology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia presents a significant clinical challenge with high mortality and morbidity rates.
  • A substantial proportion of MRSA bacteraemia cases occur within 72 hours of hospital admission, often linked to prior healthcare exposure.

Purpose of the Study:

  • To analyze the characteristics, risk factors, and outcomes of MRSA bacteraemia episodes in a UK district general hospital.
  • To identify key factors influencing mortality and inform strategies for improved patient management.

Main Methods:

  • Retrospective analysis of 76 MRSA bacteraemia episodes over a four-year period.
  • Data collection included patient demographics, comorbidities, clinical diagnoses, previous treatments, and acquisition risk factors.
  • Mortality rates at 7 days and 3 months were assessed.

Main Results:

  • The overall mortality rates at 7 days and 3 months were 31.5% and 53.4%, respectively.
  • Common comorbidities included multiple chronic conditions and pneumonia; 10 patients died before targeted therapy initiation.
  • Identified risk factors for MRSA infection included prior antibiotic use, advanced age, surgical ward/ICU admission, and presence of invasive devices (central venous catheters, urinary catheters).
  • Nearly half of the episodes (48.7%) occurred in patients not previously known to be colonized with MRSA.

Conclusions:

  • Patients with risk factors for MRSA should receive prompt empirical targeted therapy for staphylococci in blood cultures.
  • Enhanced screening protocols may be necessary to reduce transmission and improve empirical antimicrobial therapy appropriateness.
  • Community MRSA decolonization strategies could help decrease the incidence of community-onset healthcare-associated bacteraemias.

Related Concept Videos

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...